Stock AMBEEPHA AMBEE PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ambee Pharmaceuticals Plc

Equities

AMBEEPHA

BD0451AMBPH6

Pharmaceuticals

End-of-day quote Dhaka S.E.
Other stock markets
 03:30:00 13/05/2024 am IST 		5-day change 1st Jan Change
735 BDT -1.92% Intraday chart for Ambee Pharmaceuticals Plc -3.34% -9.88%
06/02 Ambee Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 Ambee Pharmaceuticals PLC Reports Earnings Results for the First Quarter Ended September 30, 2023 CI

Valuation

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Capitalization 1 1,420 1,550 1,154 985.2 1,260 1,318
Enterprise Value (EV) 1 1,651 1,765 1,370 1,210 1,588 1,682
P/E ratio 172 x 460 x 317 x -75.7 x 156 x 145 x
Yield 0.51% 0.46% 0.31% - 0.19% 0.27%
Capitalization / Revenue 4.06 x 4.83 x 4.04 x 9.95 x 6.96 x 6.65 x
EV / Revenue 4.73 x 5.5 x 4.8 x 12.2 x 8.77 x 8.49 x
EV / EBITDA 61.5 x 63.2 x 75.6 x -724 x 80.9 x 83.4 x
EV / FCF -115 x 63 x 217 x -489 x -15.2 x 1,497 x
FCF Yield -0.87% 1.59% 0.46% -0.2% -6.6% 0.07%
Price to Book 23 x 26.8 x 19.9 x 22 x 23.9 x 56.5 x
Nbr of stocks (in thousands) 2,400 2,400 2,400 2,400 2,400 2,400
Reference price 2 591.7 645.9 480.7 410.5 525.1 549.1
Announcement Date 13/11/19 27/11/20 27/06/21 14/12/21 10/12/22 07/12/23
1BDT in Million2BDT
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net sales 1 349.4 321.2 285.3 98.98 181 198.1
EBITDA 1 26.86 27.94 18.12 -1.672 19.64 20.16
EBIT 1 17.81 20.09 11.5 -7.282 14.86 13.17
Operating Margin 5.1% 6.25% 4.03% -7.36% 8.21% 6.65%
Earnings before Tax (EBT) 1 11.02 13.11 4.94 -12.28 10.23 10.68
Net income 1 8.264 3.367 3.637 -13.01 8.059 9.09
Net margin 2.37% 1.05% 1.27% -13.14% 4.45% 4.59%
EPS 2 3.443 1.403 1.515 -5.421 3.358 3.788
Free Cash Flow 1 -14.35 28.01 6.329 -2.474 -104.8 1.124
FCF margin -4.11% 8.72% 2.22% -2.5% -57.9% 0.57%
FCF Conversion (EBITDA) - 100.25% 34.93% - - 5.57%
FCF Conversion (Net income) - 831.95% 174.03% - - 12.36%
Dividend per Share 2 3.000 3.000 1.500 - 1.000 1.500
Announcement Date 13/11/19 27/11/20 27/06/21 14/12/21 10/12/22 07/12/23
1BDT in Million2BDT
Estimates

Balance Sheet Analysis

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net Debt 1 231 215 217 225 328 364
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 8.611 x 7.695 x 11.96 x -134.4 x 16.7 x 18.05 x
Free Cash Flow 1 -14.4 28 6.33 -2.47 -105 1.12
ROE (net income / shareholders' equity) 13.5% 5.64% 6.29% -25.3% 16.5% 23.9%
ROA (Net income/ Total Assets) 2.49% 2.96% 1.73% -1.07% 2.01% 1.62%
Assets 1 332.4 113.6 210.3 1,214 401.7 562.2
Book Value Per Share 2 25.70 24.10 24.10 18.70 22.00 9.730
Cash Flow per Share 2 5.270 2.320 4.630 6.290 7.050 11.90
Capex 1 5.77 0.37 0.71 - 1.53 0.11
Capex / Sales 1.65% 0.11% 0.25% - 0.85% 0.05%
Announcement Date 13/11/19 27/11/20 27/06/21 14/12/21 10/12/22 07/12/23
1BDT in Million2BDT
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
AMBEE PHARMACEUTICALS PLC Stock Ambee Pharmaceuticals Plc
-9.88% 15.4M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.09% 43.27B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+25.28% 22.92B
SANDOZ GROUP AG Stock Sandoz Group AG
+19.22% 15.43B
CIPLA LIMITED Stock Cipla Limited
+13.51% 12.95B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.01% 11.83B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-7.79% 6.91B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.02% 5.55B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AMBEEPHA Stock
  4. Financials Ambee Pharmaceuticals Plc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW